In contrast, glucosylceramide synthase (GCS), dihydroceramide synthase (LASS4, LASS6), and acidic ceramidase (ASAH1) were expressed at higher levels in estrogen receptor-positive BC (29). Here, CERS4 is linked to breast cancer.